Quarterly report pursuant to Section 13 or 15(d)

Debt (Tables)

v3.20.2
Debt (Tables)
 9 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Interest Rate Contracts
The following table presents information related to interest rate contracts entered into by the Company and designated as cash flow hedges:
June 30, 2020 September 30, 2019
Pay fixed swaps - notional amount $ 343,750    $ 293,750   
Net unrealized loss
$ (6,269)   $ (534)  
Weighted-average maturity period (years) 2.6 1.9
Weighted-average received rate 0.16  % 2.02  %
Weighted-average pay rate 1.33  % 1.41  %
Interest Rate Swap Contracts as Reflected on Balance Sheet
At June 30, 2020 and September 30, 2019, the interest rate swap contracts were reflected in the Consolidated Balance Sheets as follows:

Derivatives June 30, 2020 September 30, 2019
Current assets:    
Other current assets $ 249    $ 548   
Long-term assets:    
Other assets 995    297   
Current liabilities:    
Other current liabilities (3,207)   (484)  
Long-term liabilities:    
Other liabilities (4,306)   (895)  
Total derivatives $ (6,269)   $ (534)  
Gain (Loss) on Derivatives
The (losses) gains recognized on derivatives were as follows:
Derivatives in Cash Flow Hedging Relationships Location of (Loss) Gain Recognized in Income on Derivative Amount of (Loss) Gain Recognized in Income on Derivatives Amount of Gain Recognized in Income on Derivatives
     Three Months Ended
June 30,		 Nine Months Ended
June 30,
    2020 2019 2020 2019
Interest rate swaps Interest expense $ (438)   $ 874    $ 108    $ 2,489   

The Company recognized the following (losses) gains in AOCI:
Derivatives in Cash Flow Hedging Relationships Amount of Loss
Recognized in AOCI on Derivatives		 Location of Gain Reclassified From AOCI into Income (Effective Portion*)
Amount of Gain
Reclassified from
AOCI into Income
(Effective Portion*)
  June 30, 2020 June 30, 2019   June 30, 2020 June 30, 2019
Interest rate swaps $ (4,248)   $ (6,074)   Interest expense $ 82    $ 1,879   
*There is no ineffective portion or amount excluded from effectiveness testing.